Probiotic supplement as an adjunctive therapy with Ritalin for treatment of attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled randomized clinical trial

被引:14
|
作者
Ghanaatgar, Milad [1 ]
Taherzadeh, Sina [2 ]
Ariyanfar, Shadi [3 ]
Razeghi, Jahromi Soodeh [1 ]
Martami, Fahime [4 ]
Mahmoudi, Gharaei Javad [5 ]
Teimourpour, Amir [6 ]
Shahrivar, Zahra [1 ,5 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Clin Nutr & Dietet, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran
[2] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Tehran, Iran
[3] Washington State Univ, Elson S Floyd Coll Med, Dept Nutr & Exercise Physiol, Vancouver, WA USA
[4] Univ Tehran Med Sci, Sch Nutrit Sci & Dietet, Tehran, Iran
[5] Univ Tehran Med Sci, Roozbeh Hosp, Tehran, Iran
[6] Blood Transfus Res Ctr, High Inst Res & Educ Transfus Med, Tehran, Iran
关键词
Attention-deficit hyperactivity disorder; ADHD; Probiotics; Children; INTESTINAL PERMEABILITY; STIMULANT MEDICATIONS; GENDER-DIFFERENCES; ALLERGIC DISEASES; ADHD; GUT; INFLAMMATION; ASSOCIATION; MICROBIOTA; SCALE;
D O I
10.1108/NFS-12-2021-0388
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Purpose Accumulating evidence highlights the importance of microbiota-directed intervention in neuropsychiatric disorders. This study aims to investigate the effects of probiotic supplements as an adjunct therapy in combination with Ritalin in children with attention-deficit hyperactivity disorder (ADHD). Design/methodology/approach Children with ADHD, aged 6-12 years, who had an intelligent quotient of >= 70 were enrolled in the study. Participants were randomly assigned to either the group that received probiotics or the group that received the placebo in addition to the weight-adjusted dose of Ritalin. Parents were asked to complete the revised Conners Parent Rating Scale-short version (CPRS-RS), and the psychiatrist completed the seven-point Clinical Global Impression-Severity (CGI-S) scale. Two study groups were compared in three time points, including T1 (before intervention), T2 (at the end of fourth week) and T3 (at the end of the eighth week). Findings A total of 38 participants completed the study. After eight weeks of intervention, the probiotic group had a significant improvement regarding CPRS-RS scores in T2 (9.4 unit, p = 0.014) and T3 (18.6 unit, p < 0.001), compared to placebo. In addition, children in the probiotic group had 0.7 unit lower CGI in T3 (p = 0.018) than the placebo group. A significant reduction of CGI scores was observed in each interval (T2 vs T1, T3 vs T2 and T3 vs T1; p < 0.05). This significant change in CGI score between intervals was also detected in the placebo group in T2 vs T1 (p = 0.002) and T3 vs T1 (p < 0.001). Mean CPRS scores of the groups were different in T2 and T3 (p = 0.011 and p < 0.001, respectively) and mean CGI scores of the two study groups were different in T3 (p = 0.018). Originality/value Eight weeks of supplementation with probiotics had a favorable effect on symptoms and severity of ADHD. Therefore, probiotics as an adjuvant treatment might have a promising efficacy regarding the management of ADHD.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 50 条
  • [31] Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder - A double-blind randomized controlled
    Skott, Elin
    Yang, Liu L.
    Stiernborg, Miranda
    Soderstrom, Asa
    Ruegg, Joelle
    Schalling, Martin
    Forsell, Yvonne
    Giacobini, MaiBritt
    Lavebratt, Catharina
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 89 : 9 - 19
  • [32] Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial
    Winhusen, Theresa M.
    Somoza, Eugene C.
    Brigham, Gregory S.
    Liu, David S.
    Green, Carla A.
    Covey, Lirio S.
    Croghan, Ivana T.
    Adler, Lenard A.
    Weiss, Roger D.
    Leimberger, Jeffrey D.
    Lewis, Daniel F.
    Dorer, Emily M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (12) : 1680 - 1688
  • [33] A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder
    Greenhill, LL
    Findling, RL
    Swanson, JM
    PEDIATRICS, 2002, 109 (03) : E39
  • [34] Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial
    Amiri, Shahrokh
    Mohammadi, Mohammad-Reza
    Mohammadi, Mohammad
    Nouroozinejad, Gholam-Hossein
    Kahbazi, Manijeh
    Akhondzadeh, Shahin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01) : 145 - 149
  • [35] A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder
    Harfterkamp, Myriam
    van de Loo-Neus, Gigi
    Minderaa, Ruud B.
    van der Gaag, Rutger-Jan
    Escobar, Rodrigo
    Schacht, Alexander
    Pamulapati, Sireesha
    Buitelaar, Jan K.
    Hoekstra, Pieter J.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2012, 51 (07) : 733 - 741
  • [36] SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study
    Brams, Matthew
    Childress, Ann C.
    Greenbaum, Michael
    Yu, Ming
    Yan, Brian
    Jaffee, Margo
    Robertson, Brigitte
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 19 - 28
  • [37] A Randomized Placebo-Controlled Trial of Electroencephalographic (EEG) Neurofeedback in Children With Attention-Deficit/Hyperactivity Disorder
    van Dongen-Boomsma, Martine
    Vollebregt, Madelon A.
    Slaats-Willemse, Dorine
    Buitelaar, Jan K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (08) : 821 - 827
  • [38] Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial
    Kelsey, DK
    Sumner, CR
    Casat, CD
    Coury, DL
    Quintana, H
    Saylor, KE
    Sutton, VK
    Gonzales, J
    Malcolm, SK
    Schuh, KJ
    Allen, AJ
    PEDIATRICS, 2004, 114 (01) : E1 - E8
  • [39] A mixed herbal extract as an adjunctive therapy for attention deficit hyperactivity disorder: A randomized placebo-controlled trial
    Bae, Sujin
    Park, Sunhye
    Han, Doug Hyun
    INTEGRATIVE MEDICINE RESEARCH, 2021, 10 (03)
  • [40] Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial
    Reham M. Elhossiny
    Heba H. Elshahawy
    Hanan M. Mohamed
    Reham I. Abdelmageed
    BMC Psychiatry, 23